Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.11851/3997
Title: Additive Effect of Topical Nepafenac on Mydriasis in Patients With Diabetes Mellitus
Authors: Kızıltoprak, Hasan
Koç, Mustafa
Yetkin, Esat
Tekin, Kemal
İnanç, Merve
Özülken, Kemal
Keywords: Cataract surgery
Diabetes mellitus
Nepafenac
Pupil dilation
Issue Date: Aug-2020
Publisher: Eye and Contact Lens Association (ECLA)
Source: Kiziltoprak, H., Koc, M., Yetkin, E., Tekin, K., Inanc, M., & Ozulken, K. (2020). Additive Effect of Topical Nepafenac on Mydriasis in Patients With Diabetes Mellitus. Eye & contact lens, 46(5), 310-313.
Abstract: OBJECTIVES: To evaluate the additive effect of topical nepafenac on pupil diameter (PD) in patients with diabetes mellitus (DM) and cataract. METHODS: This prospective comparative study included the patients having cataract surgery with and without DM. Two consecutive PD measurements were taken using an automatic quantitative pupillometry system (MonPack One, Metrovision). A baseline measurement was taken, then one drop of nepafenac % 0.1 (Nevanac; Alcon, Fort Worth, TX) was instilled only to the eye that will be operated on (study eye). Cyclopentolate 1.0% (Sikloplejin; Abdi İbrahim, İstanbul, Turkey) was instilled to both eyes (study eye/fellow eye) 5 minutes later. The second measurement was taken at 1 hour after this application. RESULTS: The DM group consisted of 43 patients, and the control group consisted of 39 participants. The baseline PDs of both eyes were similar in the DM group (P=0.070) and the control group (P=0.345). The change in pupil size from baseline to mydriasis was statistically significantly greater in the study eyes (2.69±0.53) than fellow eyes (2.54±0.61) in the DM group (P=0.009), but there was no statistically significant difference in the control group (2.94±0.63 vs. 2.86±0.58). When the groups were compared, the PD changes were similar in the study eyes between groups (P=0.065), while the PD changes in the fellow eyes were lower in the DM group (P=0.017). CONCLUSIONS: Nepafenac has been shown additive effect on pupil dilation in diabetic patients before cataract surgery.
URI: https://hdl.handle.net/20.500.11851/3997
https://doi.org/10.1097/ICL.0000000000000657
ISSN: 1542-233X
Appears in Collections:Cerrahi Tıp Bilimleri Bölümü / Department of Surgical Sciences
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record

CORE Recommender

Page view(s)

24
checked on Dec 5, 2022

Google ScholarTM

Check

Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.